NAA15 Antikörper (N-Term)
Kurzübersicht für NAA15 Antikörper (N-Term) (ABIN953604)
Target
Alle NAA15 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 156-185, N-Term
-
Spezifität
- This antibody recognizes Human NARG1 (N-term).
-
Aufreinigung
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 156-185 amino acids from the N-terminal region of human NARG1
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- NAA15 (N(alpha)-Acetyltransferase 15, NatA Auxiliary Subunit (NAA15))
-
Andere Bezeichnung
- NARG1
-
Hintergrund
- This gene encodes a protein of unknown function. However, similarity to proteins in yeast and other species suggests that this protein may be an N-acetyltransferase.Synonyms: GA19, Gastric cancer antigen Ga19, N-terminal acetyltransferase, NATH, NMDA receptor-regulated protein 1, Protein tubedown-1, TBDN100, Tbdn100
-
Molekulargewicht
- 101272 Da
-
Gen-ID
- 80155
-
NCBI Accession
- NP_476516
Target
-